3-50364674-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_006030.4(CACNA2D2):​c.3424C>G​(p.Arg1142Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000726 in 1,377,096 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1142C) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.3e-7 ( 0 hom. )

Consequence

CACNA2D2
NM_006030.4 missense

Scores

2
2
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.19

Publications

0 publications found
Variant links:
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
CACNA2D2 Gene-Disease associations (from GenCC):
  • cerebellar atrophy with seizures and variable developmental delay
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11513448).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006030.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D2
NM_006030.4
MANE Select
c.3424C>Gp.Arg1142Gly
missense
Exon 38 of 38NP_006021.2Q9NY47-2
CACNA2D2
NM_001174051.3
c.3445C>Gp.Arg1149Gly
missense
Exon 39 of 39NP_001167522.1Q9NY47-1
CACNA2D2
NM_001005505.3
c.3430C>Gp.Arg1144Gly
missense
Exon 38 of 38NP_001005505.1Q9NY47-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D2
ENST00000424201.7
TSL:1 MANE Select
c.3424C>Gp.Arg1142Gly
missense
Exon 38 of 38ENSP00000390329.2Q9NY47-2
CACNA2D2
ENST00000423994.6
TSL:5
c.3454C>Gp.Arg1152Gly
missense
Exon 39 of 39ENSP00000407393.2C9JVC9
CACNA2D2
ENST00000479441.1
TSL:1
c.3445C>Gp.Arg1149Gly
missense
Exon 39 of 39ENSP00000418081.1Q9NY47-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
7.26e-7
AC:
1
AN:
1377096
Hom.:
0
Cov.:
32
AF XY:
0.00000148
AC XY:
1
AN XY:
677330
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
30656
American (AMR)
AF:
0.00
AC:
0
AN:
32000
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24234
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35408
South Asian (SAS)
AF:
0.00
AC:
0
AN:
77716
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47726
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4084
European-Non Finnish (NFE)
AF:
9.36e-7
AC:
1
AN:
1068412
Other (OTH)
AF:
0.00
AC:
0
AN:
56860
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Developmental and epileptic encephalopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0070
T
Eigen
Benign
-0.34
Eigen_PC
Benign
-0.12
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.59
T
M_CAP
Benign
0.083
D
MetaRNN
Benign
0.12
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
1.2
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-0.47
N
REVEL
Benign
0.12
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.0
B
Vest4
0.080
MutPred
0.26
Loss of stability (P = 0.0038)
MVP
0.043
MPC
1.0
ClinPred
0.53
D
GERP RS
4.7
Varity_R
0.25
gMVP
0.67
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs376300457; hg19: chr3-50402105; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.